Concepts (121)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hepatitis | 4 | 2022 | 65 | 1.390 |
Why?
|
| Complement System Proteins | 4 | 2010 | 58 | 0.990 |
Why?
|
| Influenza Vaccines | 4 | 2025 | 468 | 0.640 |
Why?
|
| Hemolytic-Uremic Syndrome | 3 | 2006 | 36 | 0.580 |
Why?
|
| Influenza, Human | 4 | 2025 | 646 | 0.580 |
Why?
|
| Adenovirus Infections, Human | 2 | 2023 | 49 | 0.410 |
Why?
|
| Membrane Cofactor Protein | 3 | 2006 | 10 | 0.410 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 2 | 2024 | 178 | 0.400 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 4 | 2025 | 1192 | 0.400 |
Why?
|
| Adenoviridae Infections | 2 | 2022 | 69 | 0.390 |
Why?
|
| Ectromelia virus | 1 | 2010 | 1 | 0.360 |
Why?
|
| Complement Inactivating Agents | 1 | 2010 | 11 | 0.360 |
Why?
|
| Immune Evasion | 1 | 2010 | 31 | 0.350 |
Why?
|
| Ectromelia, Infectious | 1 | 2008 | 1 | 0.330 |
Why?
|
| Virulence Factors | 1 | 2010 | 171 | 0.320 |
Why?
|
| Viral Proteins | 1 | 2010 | 348 | 0.310 |
Why?
|
| Acute Disease | 4 | 2022 | 1090 | 0.290 |
Why?
|
| Liver Transplantation | 2 | 2023 | 1033 | 0.230 |
Why?
|
| Child | 13 | 2025 | 24063 | 0.210 |
Why?
|
| Adenoviruses, Human | 1 | 2022 | 82 | 0.200 |
Why?
|
| Liver Failure, Acute | 1 | 2023 | 88 | 0.190 |
Why?
|
| Antibodies, Viral | 2 | 2025 | 1131 | 0.190 |
Why?
|
| Cytomegalovirus | 1 | 2021 | 269 | 0.170 |
Why?
|
| Gastroenteritis | 1 | 2023 | 332 | 0.170 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 3 | 2025 | 118 | 0.170 |
Why?
|
| Lung Transplantation | 1 | 2021 | 316 | 0.140 |
Why?
|
| Transplant Recipients | 3 | 2024 | 210 | 0.140 |
Why?
|
| Betacoronavirus | 1 | 2020 | 289 | 0.140 |
Why?
|
| Complement Activation | 2 | 2006 | 50 | 0.130 |
Why?
|
| Mutation | 2 | 2006 | 5734 | 0.130 |
Why?
|
| Viremia | 2 | 2022 | 128 | 0.130 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 360 | 0.120 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 378 | 0.120 |
Why?
|
| Physicians | 1 | 2021 | 582 | 0.120 |
Why?
|
| Hemagglutination Inhibition Tests | 2 | 2025 | 113 | 0.120 |
Why?
|
| Cell Line | 3 | 2010 | 2782 | 0.110 |
Why?
|
| Immunogenicity, Vaccine | 2 | 2025 | 93 | 0.110 |
Why?
|
| Child, Preschool | 6 | 2025 | 13777 | 0.110 |
Why?
|
| Humans | 17 | 2025 | 122293 | 0.110 |
Why?
|
| Alabama | 2 | 2022 | 40 | 0.100 |
Why?
|
| Infant | 5 | 2025 | 12302 | 0.090 |
Why?
|
| Exons | 2 | 2006 | 793 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 2 | 2010 | 4366 | 0.090 |
Why?
|
| Cricetulus | 1 | 2010 | 99 | 0.090 |
Why?
|
| Cricetinae | 1 | 2010 | 403 | 0.090 |
Why?
|
| Neutralization Tests | 1 | 2010 | 238 | 0.090 |
Why?
|
| Hepatitis, Viral, Animal | 1 | 2008 | 3 | 0.080 |
Why?
|
| Complement C4 | 1 | 2008 | 5 | 0.080 |
Why?
|
| Complement Factor B | 1 | 2008 | 11 | 0.080 |
Why?
|
| Complement C3 | 1 | 2008 | 47 | 0.080 |
Why?
|
| Necrosis | 1 | 2008 | 212 | 0.080 |
Why?
|
| Immunity, Innate | 1 | 2008 | 374 | 0.070 |
Why?
|
| Complement C3b | 1 | 2005 | 7 | 0.070 |
Why?
|
| Adolescent | 4 | 2025 | 18940 | 0.060 |
Why?
|
| Virus Replication | 1 | 2008 | 603 | 0.060 |
Why?
|
| Mice | 3 | 2010 | 17546 | 0.060 |
Why?
|
| Pandemics | 2 | 2022 | 1102 | 0.060 |
Why?
|
| Escherichia coli Infections | 1 | 2005 | 191 | 0.060 |
Why?
|
| Seasons | 1 | 2025 | 300 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 1296 | 0.050 |
Why?
|
| Antibody Formation | 1 | 2024 | 255 | 0.050 |
Why?
|
| Vaccines, Inactivated | 1 | 2024 | 144 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2008 | 3770 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2024 | 323 | 0.050 |
Why?
|
| Ganciclovir | 1 | 2021 | 105 | 0.050 |
Why?
|
| Liver | 1 | 2008 | 1851 | 0.050 |
Why?
|
| Homeostasis | 1 | 2005 | 680 | 0.050 |
Why?
|
| Untranslated Regions | 1 | 2000 | 8 | 0.050 |
Why?
|
| Male | 5 | 2025 | 59520 | 0.050 |
Why?
|
| Receptors, Chemokine | 1 | 2000 | 44 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2004 | 1000 | 0.050 |
Why?
|
| Public Health | 1 | 2022 | 252 | 0.040 |
Why?
|
| Trans-Activators | 1 | 2004 | 804 | 0.040 |
Why?
|
| Adenoviridae | 1 | 2023 | 637 | 0.040 |
Why?
|
| Eosinophils | 1 | 2000 | 120 | 0.040 |
Why?
|
| Animals | 3 | 2010 | 33721 | 0.040 |
Why?
|
| Vaccination | 1 | 2025 | 927 | 0.040 |
Why?
|
| Tissue Donors | 1 | 2022 | 498 | 0.040 |
Why?
|
| Young Adult | 2 | 2025 | 8760 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2004 | 1703 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2004 | 1674 | 0.030 |
Why?
|
| Prognosis | 1 | 2006 | 4488 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2000 | 1354 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2021 | 736 | 0.030 |
Why?
|
| Asthma | 1 | 2004 | 743 | 0.030 |
Why?
|
| Hospitals, Pediatric | 1 | 2020 | 776 | 0.030 |
Why?
|
| Adult | 2 | 2022 | 28732 | 0.030 |
Why?
|
| Female | 3 | 2025 | 64882 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2004 | 4282 | 0.030 |
Why?
|
| Hospitalization | 1 | 2020 | 1727 | 0.020 |
Why?
|
| Texas | 1 | 2020 | 3528 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2020 | 8096 | 0.020 |
Why?
|
| Haplotypes | 1 | 2006 | 510 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2020 | 12044 | 0.010 |
Why?
|
| Antigens, Fungal | 1 | 2004 | 34 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 2004 | 74 | 0.010 |
Why?
|
| Aspergillus fumigatus | 1 | 2004 | 41 | 0.010 |
Why?
|
| STAT6 Transcription Factor | 1 | 2004 | 36 | 0.010 |
Why?
|
| Administration, Intranasal | 1 | 2004 | 128 | 0.010 |
Why?
|
| Ovalbumin | 1 | 2004 | 316 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2021 | 15853 | 0.010 |
Why?
|
| Allergens | 1 | 2004 | 244 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2004 | 979 | 0.010 |
Why?
|
| Kidney Transplantation | 1 | 2006 | 621 | 0.010 |
Why?
|
| Receptors, CCR3 | 1 | 2000 | 5 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2000 | 260 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 2000 | 211 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2000 | 351 | 0.010 |
Why?
|
| Transfection | 1 | 2000 | 1076 | 0.010 |
Why?
|
| Alternative Splicing | 1 | 2000 | 346 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2000 | 805 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2000 | 799 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2000 | 1592 | 0.010 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2000 | 541 | 0.010 |
Why?
|
| Base Sequence | 1 | 2000 | 3109 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2000 | 3865 | 0.010 |
Why?
|
| DNA | 1 | 2000 | 1606 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2000 | 1750 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2000 | 2826 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2000 | 2534 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2004 | 4511 | 0.010 |
Why?
|